RecruitingNot ApplicableNCT04751435

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

IMAGINE: IMproving Access to Genetic INformation for Everyone - A Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

445 participants

Start Date

Nov 16, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Genetic testing is a type of test that detects changes to the genes-the DNA instructions that are passed on from the mother and father. The results of a genetic test can confirm whether the participant has a genetic disorder, which is a disease caused in whole or in part by changes to the genes. Genetic testing can also help determine a person's chance of getting or passing on a genetic disorder. Genetic tests use a sample of blood, hair, skin, or other tissue, and they can look at one gene or multiple genes at the same time. Genetic testing may change the options for treating people with certain types of cancer. For example, some medications are more helpful for the treatment of cancer in people with certain gene changes (mutations). The researchers are doing this study to develop new educational materials about genetic testing for people who speak different languages and have diverse cultural and educational backgrounds. During the study, the staff will interview participants with diverse cultural and educational backgrounds and ask them to review a sample of the educational materials that have been developed so far. Participants will give their opinions on these materials, and the researchers will use participants' feedback to improve the materials.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing new educational materials about genetic testing for cancer risk, specifically designed for diverse groups of cancer patients, including Black and Latino communities. **You may be eligible if...** - You are 18 years or older - You have a current or past diagnosis of breast, ovarian, pancreatic, or prostate cancer - You identify as Black, Latino, or non-Black/non-Latino - You speak English, Haitian Creole, or Spanish (depending on study phase) **You may NOT be eligible if...** - You are under 18 years old - You do not have one of the qualifying cancer diagnoses Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCognitive interview

Researchers will use formative methods to adapt our previously-developed mainstreaming pre-genetic test educational materials plus standard post-test clinical communication materials used by the MSK CGS for use with the diverse patients. Specifically, it will adapt these materials to be responsive to patients' linguistic and literacy needs, and sensitive to their cultural diversity.

BEHAVIORALLCAM intervention

Participants will receive adapted pretest educational materials from study staff and/or clinical staff and have testing ordered by their oncologist, followed by post-test genetic counseling via telegenetics with a health and genetic "literacy screener" and adapted clinical communication materials.

BEHAVIORALStandard of care

Participants will receive in-depth pre-test and post-test genetic counseling provided via telegenetics


Locations(4)

Kings County Hopsital Center

Brooklyn, New York, United States

Queens Cancer Center of Queens Hospital

Jamaica, New York, United States

Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities)

New York, New York, United States

Jamaica Hospital Medical Center (Data Collection Only)

Richmond Hill, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04751435


Related Trials